Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ticlopidine and aspirin interactions

L Gregorini¹, J Marco

¹Clinica Medica Generale, Università di Milano, Ospedale Maggiore IRCCS, Italy.

Heart (British Cardiac Society)

|January 1, 1997

Summary

Comparing aspirin alone versus aspirin with ticlopidine, current multicentre trials suggest the combination therapy offers a better risk-benefit profile. This approach may improve vessel patency post-stent implantation despite potential neutropenia risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Search for massive WH resonances decaying into the [Formula: see text] final state at [Formula: see text][Formula: see text].

The European physical journal. C, Particles and fields·2017

Same author

Forward-backward asymmetry of Drell-Yan lepton pairs in pp collisions at [Formula: see text][Formula: see text].

The European physical journal. C, Particles and fields·2017

Same author

Search for heavy resonances decaying to two Higgs bosons in final states containing four b quarks.

The European physical journal. C, Particles and fields·2017

Same author

Measurements of the [Formula: see text] production cross section in lepton+jets final states in pp collisions at 8 [Formula: see text] and ratio of 8 to 7 [Formula: see text] cross sections.

The European physical journal. C, Particles and fields·2017

Same author

Search for Dark Matter and Supersymmetry with a Compressed Mass Spectrum in the Vector Boson Fusion Topology in Proton-Proton Collisions at sqrt[s]=8 TeV.

Physical review letters·2017

Same author

Search for Resonant Production of High-Mass Photon Pairs in Proton-Proton Collisions at sqrt[s]=8 and 13 TeV.

Physical review letters·2016

Area of Science:

Cardiology
Pharmacology
Interventional Cardiology

Background:

Cardiologists debate antiplatelet strategies post-stent implantation.
Two main approaches exist: aggressive antiplatelet therapy (aspirin plus ticlopidine) or aspirin monotherapy with IVUS guidance.
Neutropenia risk (0.7%) is a concern with ticlopidine, while aspirin monotherapy may lead to increased coagulation activation.

Purpose of the Study:

To investigate the risk-benefit balance of aspirin compared to aspirin plus ticlopidine.
To evaluate different antiplatelet strategies in multicentre trials.
To assess the efficacy and safety of combined antiplatelet regimens versus monotherapy.

Main Methods:

Several multicentre trials (MUSIC, WEST II, TASTE, MUST, STARS) are comparing treatment regimens.
Cardiologists employ distinct strategies based on risk tolerance and cost-effectiveness.
Intravascular ultrasound (IVUS) is used to ensure stent expansion and lesion coverage in monotherapy approaches.

Main Results:

The study is ongoing, with preliminary impressions favoring the combination of ticlopidine and aspirin.
The combination therapy appears to offer a more favorable risk-effect balance.
Aggressive antiplatelet therapy aims to maintain vessel patency, while monotherapy prioritizes cost-saving and IVUS evaluation.

Conclusions:

The combination of ticlopidine and aspirin is suggested to have a more favorable risk-effect balance.
Further results from ongoing multicentre trials are anticipated to confirm these findings.
The choice of antiplatelet strategy involves balancing efficacy, safety, and cost considerations.

Related Experiment Videos